טוען...
Kinase inhibitors for advanced medullary thyroid carcinoma
The recent availability of molecular targeted therapies leads to a reconsideration of the treatment strategy for patients with distant metastases from medullary thyroid carcinoma. In patients with progressive disease, treatment with kinase inhibitors should be offered.
שמור ב:
| Main Authors: | , , , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo
2012
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3328820/ https://ncbi.nlm.nih.gov/pubmed/22584717 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.6061/clinics/2012(Sup01)21 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|